PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease

COMMENTED

Type 1 Diabetes

Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis

Eur J Endocrinol.

Nederstigt C, Uitbeijerse B, Janssen L, Corssmit EP, de Koning E, Dekkers O

doi: 10.1530/EJE-18-0515.

COMMENTED

Type 2 Diabetes

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Circulation.

Mann JFE, Fonseca V, Mosenzon O, Raz I, Goldman B, Idorn T, von Scholten BJ, Poulter NR

doi: 10.1161/CIRCULATIONAHA.

COMMENTED

Type 1 DiabetesGlycemic Control

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Diabetes Care.

Dandona P, Mathieu C, Phillip M, Hansen L, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators

doi: 10.2337/dc18-1087.

COMMENTED

Type 2 Diabetes

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

Diabetes Care.

Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG

doi: 10.2337/dc18-0431.

COMMENTED

Diabetes - GeneralType 1 DiabetesThyroid

Incidence and Risk of Celiac Disease after Type 1 Diabetes: A Population-Based Cohort Study Using The Health Improvement Network Database

Pediatr Diabetes.

Vajravelu ME, Keren R, Weber DR, Verma R, De León DD, Denburg MR

doi: 10.1111/pedi.12770.

Diabetes - GeneralType 1 Diabetes

Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes

Diabetes Obes Metab.

Harjutsalo V, Thomas MC, Forsblom C, Groop PH; FinnDiane Study Group

doi: 10.1111/dom.13456.

Type 1 Diabetes

Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 years in Adults With Type 1 Diabetes: The CACTI Study

Diabetes Care.

Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZ, Wong R, Rewers MJ, Snell-Bergeon JK

doi: 10.2337/dc18-1527.

Type 1 Diabetes

Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring

Diabetes Obes Metab.

Pettus J, Gill J, Paranjape S, Stewart J, Malla S, Edelman S, Bergenstal RM, Bode B

doi: 10.1111/dom.13751.

Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery

Clinical and Patient-Centered Outcomes in Obese Type 2 Diabetes Patients 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study

Diabetes Care.

Simonson DC, Halperin F, Foster K, Vernon A, Goldfine AB

doi: 10.2337/dc17-0487.

Related content

Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

Incidence and Risk of Celiac Disease after Type 1 Diabetes: A Population-Based Cohort Study Using The Health Improvement Network Database

Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes

Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 years in Adults With Type 1 Diabetes: The CACTI Study

Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring

Clinical and Patient-Centered Outcomes in Obese Type 2 Diabetes Patients 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study